** Eye drug developer's shares EYEG.O drop 17.8% to $10.03
in afternoon trade
** Co announces offering of 500,000 shares at $10 each,
representing an 18% discount to the stock's last closing price
on Monday urn:newsml:reuters.com:*:nFWN29505L
** Co says it intends to use net proceeds to support
operations, including clinical trials
** Offer size represents 15.6% of co's free float
** The offering is expected to close on or about Jan. 3,
2020
** Including session's losses, stock up ~44% YTD
(Reporting by Shradha Singh in Bengaluru)
((Shradha.Singh@thomsonreuters.com; within U.S. +1 646 223 8780
Ext: 2439, outside U.S. +91 80 6749 2439;))